Postponement in sales of key molecules plays spoilsport

Company
11 Mar 2024
5 Min read 
  • Navin Fluorine International (NFIL) reported lower-than-expected EBITDA/adj. PAT in 3QFY24.
  •  The postponement of sales of key molecules and channel inventory destocking affected performance.
  •  The Specialty Chemical segment disappointed due to deferment of sales campaigns.
  •  NFIL added one molecule in Dahej and has four more in the pipeline for 4Q.
  •  The company expects stabilization in pricing pressure in R22 exports by 1QFY25.
  •  NFIL has entered into a strategic partnership with a US-based CDMO player.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority